Thorax · 2023 · 27 citations · 22 references
MedicineClinical SciencesInfectious DiseasesAutoimmunityImmunopathologyPulmonologyAutoimmune DiseasesPulmonary InfectionsPulmonary PathologyRespiratory DiseaseRespiratory InfectionsRespiratory Infectious DiseasesOpportunistic Pulmonary InfectionsPulmonary Pathogenesis
BACKGROUND: Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease, predisposing to an increased risk of infection. A complete picture of these infections is lacking. RESEARCH QUESTION: Describe the characteristics and clinical outcomes of patients diagnosed with aPAP, and to identify risk factors associated with opportunistic infections. METHODS: We conducted a retrospective cohort including all patients diagnosed with aPAP between 2008 and 2018 in France and Belgium. Data were collected using a standardised questionnaire including demographics, comorbidities, imaging features, outcomes and microbiological data. RESULTS: spp was the main pathogen identified (n=10). Thirty-five (34%) patients were hospitalised due to infection. In univariate analysis, male gender was associated with opportunistic infections (p=0.04, OR=3.88; 95% CI (1.02 to 22.06)). Anti-granulocyte macrophage colony-stimulating factor antibody titre at diagnosis was significantly higher among patients who developed nocardiosis (1058 (316-1591) vs 580 (200-1190), p=0.01). Nine patients had died (9%), but only one death was related to infection. INTERPRETATION: Patients with aPAP often presented with opportunistic infections, especially nocardiosis, which highlights the importance of systematic search for slow-growing bacteria in bronchoalveolar lavage or whole lung lavage.
22
Edouard G. Stanley, Graham J. Lieschke, D Grail et al. · Proceedings of the National Academy of Sciences · 1994 · 884 citations
Life Sciences, Immunology, Pathology +14
Takayuki Kitamura, Naohiko Tanaka, Junichi Watanabe et al. · The Journal of Experimental Medicine · 1999 · 559 citations · Full text
Medicine, Immunology, Pathology +13